A detailed history of Mml Investors Services, LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Mml Investors Services, LLC holds 9,492 shares of VCYT stock, worth $394,297. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,492
Previous 9,566 0.77%
Holding current value
$394,297
Previous $207,000 56.04%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$21.0 - $35.25 $1,554 - $2,608
-74 Reduced 0.77%
9,492 $323,000
Q2 2024

Aug 14, 2024

SELL
$18.86 - $23.55 $13,899 - $17,356
-737 Reduced 7.15%
9,566 $207,000
Q1 2024

May 14, 2024

SELL
$21.0 - $29.1 $8,379 - $11,610
-399 Reduced 3.73%
10,303 $228,000
Q4 2023

Feb 14, 2024

BUY
$19.72 - $28.68 $34,017 - $49,473
1,725 Added 19.22%
10,702 $294,000
Q3 2023

Nov 14, 2023

BUY
$22.33 - $29.92 $9,601 - $12,865
430 Added 5.03%
8,977 $200,000
Q2 2023

Aug 14, 2023

BUY
$20.96 - $26.99 $179,145 - $230,683
8,547 New
8,547 $218,000

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $2.97B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Mml Investors Services, LLC Portfolio

Follow Mml Investors Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mml Investors Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mml Investors Services, LLC with notifications on news.